Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1996 | 06-1996 | 03-1996 | 12-1995 | 09-1995 | |
| Assets | |||||
| Current Assets | |||||
| Marketable Securities | 30 | 40 | 10 | 8 | 70 |
| Receivables | 40 | 50 | 10 | 50 | 10 |
| Inventories | 7 | N/A | N/A | N/A | 1 |
| Other current assets | 13 | 10 | 10 | 2 | -1 |
| TOTAL | $90 | $100 | $30 | $60 | $80 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 10 | 10 | 10 | 10 | 10 |
| TOTAL | $10 | $10 | $10 | $10 | $10 |
| Total Assets | $120 | $140 | $70 | $100 | $120 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $880 | $680 | $530 | $400 | $840 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 |
| TOTAL | $1,500 | $1,500 | $1,500 | $1,500 | $1,500 |
| Total Liabilities | $2,380 | $2,180 | $2,030 | $1,900 | $2,340 |
| Shareholders' Equity | |||||
| Common Shares | 180 | 180 | 180 | 180 | 140 |
| Retained earnings | -20,830 | -20,610 | -20,470 | -20,310 | -20,130 |
| Other shareholders' equity | 10 | 10 | 20 | 10 | 10 |
| TOTAL | $-2,730 | $-2,500 | $-2,410 | $-2,280 | $-2,690 |
| Total Liabilities And Equity | $-350 | $-320 | $-380 | $-380 | $-350 |